We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Amarin Sues FDA for More Exclusivity for Fish Oil Drug
Amarin Sues FDA for More Exclusivity for Fish Oil Drug
Amarin has sued the FDA, seeking five years of market exclusivity for its prescription fish oil drug Vascepa, which the agency last week granted only three years of exclusivity.